مقالات در نشریات
- 41. Imani, M., Kazemi, S., Saviz, M., (...), Sadeghi, B., Faraji ,& dana, R.,Morphological Changes Induced By Extremely Low-Frequency Electric Fields,Bioelectromagnetics,2019.
- 42. Darvishi, B., Majidzadeh ,& A, K., Ghadirian, R., Mosayebzadeh, M., Farahmand, L.,Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies,Life Sciences,2019.
- 43. Mansouri, S., Feizi, N., Mahdi, A., Majidzadeh ,& A, K., Farahmand, L.,A review on the role of VEGF in tamoxifen resistance,Anti-Cancer Agents in Medicinal Chemistry,2018.
- 44. Farahmand, L., Mansouri, S., Jafarbeik , Iravani, N., Teymourzadeh, A., Majidzadeh , A, K.,Stemness phenotype in tamoxifen resistant breast cancer cells may be induced by interactions between receptor tyrosine kinases and ERalpha-66,Recent Patents on Anti-Cancer Drug Discovery,2018.
- 45. Darvishi, B., Farahmand, L., Jalili, N., Majidzadeh ,& A, K.,Probable mechanisms involved in immunotoxin mediated capillary leak syndrome (CLS) and recently developed countering strategies,Current Molecular Medicine,2018.
- 46. Mansouri, S., Farahmand, L., Teymourzadeh, A., Majidzadeh ,& A, K.,Clinical evidence on the magnitude of change in growth pathway activity in relation to tamoxifen resistance is required,Current Cancer Drug Targets,2018.
- 47. Farahmand, L., Merikhian, P., Jalili, N., Darvishi, B., Majidzadeh ,& A, K.,Significant role of MUC1 in development of resistance to currently existing anti-cancer therapeutic agents,Current Cancer Drug Targets,2018.
- 48. Esmaeili, R., Abdoli, N., Yadegari, F., (...), Kaviani, A., Majidzadeh ,& A, K.,Unique CD44 intronic SNP is associated with tumor grade in breast cancer: A case control study and in silico analysis,Cancer Cell International,2018.
- 49. Farahmand, L., Esmaeili, R., Eini, L., Majidzadeh ,& A, K.,The effect of mesenchymal stem cell-conditioned medium on proliferation and apoptosis of breast cancer cell line,Journal of Cancer Research and Therapeutics,2018.
- 50. Moradi ,& Kalbolandi, S., Hosseinzade, A., Salehi, M., Merikhian, P., Farahmand, L.,Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER,Journal of Pharmacy and Pharmacology,2018.
- 51. Farahmand, L., Darvishi, B., Salehi, M., Samadi Kouchaksaraei, S., Majidzadeh ,& A, K.,Functionalised nanomaterials for eradication of CSCs, a promising approach for overcoming tumour heterogeneity,Journal of Drug Targeting,2018.
- 52. Seyfoori, A., Samiei, E., Jalili, N., (...), Majidzadeh ,& A, K., Akbari, M.,Self-filling microwell arrays (SFMAs) for tumor spheroid formation,Lab on a Chip,2018.
- 53. Mansouri, S., Teymourzadeh, A., Farahmand, L., Majidzadeh ,& A, K.,Challenges of endocrine therapy in breast cancer,Cancer Genetics and Psychotherapy,2017.
- 54. Mansouri, S., Naghavi , al , Hosseini, F., Farahmand, L., Majidzadeh , A, K.,MED1 may explain the interaction between receptor tyrosine kinases and ERalpha66 in the complicated network of Tamoxifen resistance,European Journal of Pharmacology,2017.
- 55. Farahmand, L., Darvishi, B., Majidzadeh ,& A, K.,Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor jb transcription factor decoy oligodeoxynucleotides,Drug Delivery,2017.
- 56. Esmaeili, R., Samadi, T., Abdoli, N., (...), Farahmand, L., Salehi, M.,The A-kinase anchoring proteins correlation with disease free survival in breast cancer,Tehran University Medical Journal,2017.
- 57. Darvishi, B., Farahmand, L., Eslami , S, Z., Majidzadeh , A, K.,NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer,Tumor Biology,2017.
- 58. Darvishi, B., Panahi, Y., Ghanei, M., Farahmand, L.,Investigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy,Basic and Clinical Pharmacology and Toxicology,2017.
- 59. Farahmand, L., Darvishi, B., Majidzadeh ,& A, K., Madjid Ansari, A.,Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/beta-catenin signalling pathways,Cell Proliferation,2017.
- 60. Madjid Ansari, A., Majidzadeh ,& A, K., Darvishi, B., (...), Farahmand, L., Norouzian, D.,Extremely low frequency magnetic field enhances glucose oxidase expression in Pichia pastoris GS115,Enzyme and Microbial Technology,2017.
نمایش ۴۱ تا ۶۰ مورد از کل ۷۵ مورد.